BioMarin Pharmaceutical
BioMarin Pharmaceutical Inc.
770 Lindaro Street
San Rafael, CA 94901
Phone: (415) 506-6700Website: https://www.biomarin.com/Careers: careers.biomarin.com
Latest news
- U.S. Food and Drug Administration Approves BioMarin's Brineura (cerliponase alfa) for Children Under 3 Years with CLN2 Disease
24 July 2024 - U.S. Food and Drug Administration Approves BioMarin's Voxzogo (vosoritide) for Children Under 5 Years with Achondroplasia
20 October 2023 - FDA Approves Roctavian (valoctocogene roxaparvovec-rvox) Gene Therapy for Adults with Severe Hemophilia A
29 June 2023 - BioMarin Announces Advancements in FDA Review of ROCTAVIAN for Adults with Severe Hemophilia A
24 November 2022 - BioMarin Resubmits Biologics License Application (BLA) for Valoctocogene Roxaparvovec AAV Gene Therapy for Severe Hemophilia A to the FDA
29 September 2022 - FDA Approves Voxzogo (vosoritide) to Increase Linear Growth in Children with Achondroplasia
19 November 2021 - BioMarin Announces Oral Presentation at ENDO2021, the Endocrine Society's Annual Meeting, with Data Demonstrating 2 Years of Treatment Benefit in Children with Achondroplasia Treated with Vosoritide
20 March 2021 - BioMarin Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to Valoctocogene Roxaparvovec, Investigational Gene Therapy for Hemophilia A
8 March 2021 - FDA Accepts BioMarin's New Drug Application for Vosoritide to Treat Children with Achondroplasia
2 November 2020 - BioMarin Submits New Drug Application to U.S. Food and Drug Administration for Vosoritide to Treat Children with Achondroplasia
20 August 2020
Drugs Associated with BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc. manufactures, markets and/or distributes more than 8 drugs in the United States. Medications listed here may also be marketed under different names in different countries. Non-US country and region specific information is not available on this page.
| Brand/Generic Name | Reviews | Rating |
|---|---|---|
|
Aldurazyme
Generic name: laronidase Drug class: lysosomal enzymes |
||
|
Brineura
Generic name: cerliponase alfa Drug class: lysosomal enzymes |
||
|
Kuvan
Generic name: sapropterin Drug class: miscellaneous metabolic agents |
||
|
Naglazyme
Generic name: galsulfase Drug class: lysosomal enzymes |
||
|
Palynziq
Generic name: pegvaliase Drug class: miscellaneous metabolic agents |
||
|
Roctavian
Generic name: valoctocogene roxaparvovec Drug class: miscellaneous coagulation modifiers |
||
|
Vimizim
Generic name: elosulfase alfa Drug class: lysosomal enzymes |
||
|
Voxzogo
Generic name: vosoritide Drug class: miscellaneous hormones |
||
| For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective). | ||